Stock Analysts

Charges Rattle Symmetry, Snips View (JNJ) (SMA) (SYK) (ZMH)

Orthopedic implants and instruments maker Symmetry Medical ’s ( SMA ) third-quarter fiscal 2011 adjusted earnings per share of 4 cents largely missed the Zacks Consensus Estimate of 12 cents and came in below the year-ago adjusted earnings of 10 cents. Adjusted earnings exclude facility consolidation expenses, acquisition and legal costs, employee severance payments and management transition costs. […]

Stock Analysts

Virgin Media Underperforms (TIVO) (VMED)

Virgin Media Inc. ( VMED ) reported weak financial results for the third quarter of 2011, which fell below the Zacks Consensus Estimates. In the previous quarter, average monthly churn rate was 1.7% compared with 1.6% in the prior-year quarter […]

Stock Analysts

Earnings Preview: NVIDIA (NVDA)

NVIDIA Corporation ( NVDA ) is scheduled to announce its third quarter 2012 results on November 9, 2011, and we do not expect much change in analysts’ estimate for the given period. Second Quarter Overview The company reported revenues of $1.02 billion in the second quarter of 2012, up 5.7% from the previous quarter and up 25.4% from the prior-year quarter. […]

Stock Analysts

Wells Fargo Accused by Loreley (BAC) (WFC)

Earlier this week, Wells Fargo Securities, a unit of Wells Fargo and Company ( WFC ) was sued by Loreley Financing, a group of special-purpose entities, Bloomberg reported. The complaint lodged claims that Wells Fargo Securities misrepresented documents in the sale of over $163.3 million of collateralized debt obligations (CDOs). […]

Stock Analysts

JEC Buys Phil Firm, Wins Contracts (FLR) (FWLT) (JEC)

Jacobs Engineering Group Inc. ( JEC ) recently reported buying of KlingStubbins, a Philadelphia based architectural firm, which was originally formed by renowned architect Vincent Kling. The terms of the transaction were not disclosed as yet KlingStubbins, with approximately 500 employees in the United States and Asia, provides professional services in planning, architecture, engineering and interiors with a market focus and specialization in Corporate/Commercial, Government, Science and Technology, Higher Education, Mission Critical and Interiors works […]

Stock Analysts

PetMed Express Remains Neutral (PETM) (PETS)

Recently, we reiterated our Neutral recommendation on PetMed Express ( PETS ) with a target price of $11.00. PetMed reported a 5% decline in revenues during the most recent quarter affected as it was by aggressive pricing in flea and tick products and introduction of generic Frontline to the market. Although the company decided against participating actively in the generic flea and tick market due to a pending litigation, it expects to be actively involved in 2012, which should improve revenues. […]